Hydroxychloroquine found ineffective on COVID-19 patients with mild symptoms: Study

A recent study conducted by University of Minnesota has revealed that Hydroxychloroquine (HCQ) offers benefit to COVID-19 infected patients with mild symptoms. Hydroxychloroquine is an anti-Malaria drug that has long been endorsed by US President Donald Trump as a cure for COVID-19, even though study has shown drug to have any effect on virus.

Re: Hydroxychloroquine Highly Politicised In US But India Uses It Widely: White House Official

HCQ has effect on mild COVID-19 

As per reports, an article published in Annals of Internal Medicine Journal states that anti-malaria drug showed decrease in severity of symptoms in n-hospitalised coronavirus patients. researchers involved in study divided participants into two groups, one group was given anti-malaria drug while or group was simply given a placebo.

According to reports, after being backed by Trump, general interest around anti-malaria drug, which has been on market for close to a year, saw a steep increase.

However, several studies, including this one conducted at University of Minnesota, have shown that drug has real effects on COVID-19 patients. Most researchers have stopped pinning ir hopes on HCQ and moved on in ir quest to finding a cure for COVID-19.

Re: Brazil's President Says Hydroxychloroquine To Cure His Virus

WHO halts Hydroxychloroquine trial

Earlier, World Health Organisation (WHO) h anunced that that it was halting trials of hydroxychloroquine and combination of HIV drug lopinavir/ritonavir, which are aimed at finding a vaccine or treatment for dely coronavirus. According to reports, WHO decided to stop testing se drugs after y did t show an improvement in mortality rate of COVID-19 patients.

In a statement, UN health body stated that trials have shown that hydroxychloroquine does t have any effect on patients and produces little to difference in mortality rates of patients. dely coronavirus pandemic which began in China last year has infected over 14 million people and killed 598,367 people across globe. Multiple companies across globe are involved in race to find a vaccine for COVID-19.

Re: WHO Halts Trial Of Hydroxychloroquine, Says Drug t Effective In COVID-19 Treatment

Re: WHO Halts Hydroxychloroquine & Combination Of HIV Drug Trials Among COVID-19 Patients